A detailed history of Aspen Grove Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aspen Grove Capital, LLC holds 2,310 shares of ABT stock, worth $261,699. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,310
Previous 2,616 11.7%
Holding current value
$261,699
Previous $272 Million 3.09%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $30,621 - $36,147
-306 Reduced 11.7%
2,310 $263 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $6,345 - $7,083
63 Added 2.47%
2,616 $272 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $279,604 - $308,810
2,553 New
2,553 $290 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $316,454 - $371,250
3,329 New
3,329 $365 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aspen Grove Capital, LLC Portfolio

Follow Aspen Grove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Grove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Grove Capital, LLC with notifications on news.